Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
15 November, 2018 12:08 IST
Sun Pharma settles patent dispute for generic Linzess
Source: IRIS | 17 Jan, 2018, 09.48AM
Comments  |  Post Comment

Sun Pharmaceutical Industries announced that its wholly owned subsidiaries have reached an agreement with Ironwood Pharmaceuticals, Inc. and Allergan plc (together known as the Companies) to resolve the patent litigation regarding submission of an Abbreviated New Drug Application (ANDA) for a generic version of Linzess (Linaclotide capsules) in the US.

Pursuant to the terms of the settlement, the Companies will grant, the wholly owned subsidiaries of Sun Pharma, (Q,N,C,F)* a license to market a generic version of Linzess in the United States beginning February 1, 2031 (subject to USFDA approval) or earlier under certain circumstances.

As a result of the settlement, all Hatch-Waxman litigation between Sun Pharma and the Companies, regarding the Linzess patents, will be dismissed. Additional details regarding the settlement were not disclosed. The agreement is subject to customary regulatory approvals.

Shares of the company declined Rs 0.25, or 0.04%, to trade at Rs 577.85. The total volume of shares traded was 59,212 at the BSE (9.34 a.m., Wednesday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Lupin receives FDA approval for Decitabine for Injection - 15-Nov-2018 12:00
Zydus Cadila receives USFDA nod for Arsenic Trioxide injection - 15-Nov-2018 10:11
ICICI Bank raises retail term-deposit interest rates by upto 25bps - 15-Nov-2018 09:55
Lupin gets approval for Budesonide inhalation suspension - 13-Nov-2018 13:36
Suven Life Sciences secures 2 overseas product patents - 13-Nov-2018 10:18
GAIL Gas signs MoU with Energy Efficiency Services - 13-Nov-2018 10:14
Lupin launches generic Atovaquone oral suspension in US - 12-Nov-2018 16:06
Zydus Cadila gets USFDAs nod for anti-fungal ointment - 12-Nov-2018 13:40
NHB sanctions Rs 35 bn refinance facility to PNB Housing Finance - 12-Nov-2018 13:17
BHEL commissions 120 MW Pulichintala hydro-electric project - 12-Nov-2018 12:55
Tata Consultancy Services partners with ENGIE Laborelec - 12-Nov-2018 12:52
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer